预防性鞘内吗啡不能预防硬膜穿刺后头痛:随机双盲试验
结果显示鞘内吗啡组硬膜穿刺后头痛发生率78%(21/27),生理盐水组79%(27/34),差异无统计学意义(-1%;95%CI -25%至24%),头痛发作时间、持续时间、严重程度及颅神经症状均无差异。结论提示产后单次预防性鞘内吗啡150 µg不能降低硬膜穿刺后头痛的发生率或严重程度。
要点
- 意外硬膜穿刺后预防性鞘内吗啡150 µg未降低硬膜穿刺后头痛发生率。
- 两组头痛发作时间、持续时间、严重程度及颅神经症状均无差异。
- 本研究不支持意外硬膜穿刺后预防性使用鞘内吗啡。
核心结论
- 产后单次预防性鞘内吗啡150 µg不能降低意外硬膜穿刺后硬膜穿刺后头痛的发生率或严重程度。
- 本研究不支持意外硬膜穿刺后预防性使用鞘内吗啡的临床价值。
研究设计与样本
- 产后随机接受鞘内吗啡150 µg或生理盐水,主要结局为硬膜穿刺后头痛发生率。
主要发现
- 硬膜穿刺后头痛发生率:鞘内吗啡组21/27(78%),生理盐水组27/34(79%),差异-1%(95%CI -25%至24%)。
- 两组头痛发作时间、持续时间、严重程度及颅神经症状均无差异。
- 硬膜外血补片使用率:鞘内吗啡组10/27(37%),生理盐水组11/21(52%),差异15%(95%CI -18%至48%)。
临床怎么用
- 意外硬膜穿刺后不应常规给予预防性鞘内吗啡150 µg以预防硬膜穿刺后头痛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prophylactic epidural morphine administration after unintentional dural puncture with a large-bore needle has been shown to decrease the incidence of post-dural puncture headache. The authors hypothesized that prophylactic administration of intrathecal morphine would decrease the incidence of post-dural puncture headache and/or need for epidural blood patch after unintentional dural puncture. METHODS: Parturients with an intrathecal catheter in situ after unintentional dural puncture with a 17-g Tuohy needle during intended epidural catheter placement for labor analgesia were enrolled in this randomized, double-blind trial. After delivery, subjects were randomized to receive intrathecal morphine 150 µg or normal saline. The primary outcome was the incidence of post-dural puncture headache. Secondary outcomes included onset, duration, and severity of post-dural puncture headache, the presence of cranial nerve symptoms and the type of treatment the patient received. RESULTS: Sixty-one women were included in the study. The incidence of post-dural puncture headache was 21 of 27 (78%) in the intrathecal morphine group and 27 of 34 (79%) in the intrathecal saline group (difference, -1%; 95% CI, -25% to 24%). There were no differences between groups in the onset, duration, or severity of headache, or presence of cranial nerve symptoms. Epidural blood patch was administered to 10 of 27 (37%) of subjects in the intrathecal morphine and 11 of 21 (52%) of the intrathecal saline group (difference 15%; 95% CI, -18% to 48%). CONCLUSIONS: The present findings suggest that a single prophylactic intrathecal morphine dose of 150 µg administered shortly after delivery does not decrease the incidence or severity of post-dural puncture headache after unintentional dural puncture. This study does not support the clinical usefulness of prophylactic intrathecal morphine after an unintentional dural puncture.
引用
- Peralta FM, Wong CA, Higgins N, et al. Prophylactic Intrathecal Morphine and Prevention of Post-Dural Puncture Headache: A Randomized Double-blind Trial. Anesthesiology. 2020. PMID: 32108686. doi:10.1097/ALN.0000000000003206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。